Posterior Nasal Nerve (PNN) Rhinitis Study

Inclusion Criteria

• Age 22 to 75 years (inclusively)
• Willing and able to provide informed consent
• Willing and able to comply with the subject-specific requirements outlined in the study protocol
• Seeking treatment for chronic rhinitis symptoms of at least 6 months duration and willing to undergo an office-based procedure
• Moderate to severe symptoms of rhinorrhea (rTNSS rating of 2 or 3 for rhinorrhea)
• Mild to severe symptoms of nasal congestion (rTNSS rating of 1, 2 or 3 for congestion)
• rTNSS score of greater than or equal to 6
• Dissatisfaction with medical management, defined as usage of intranasal steroids for a minimum of 4 weeks without adequate symptom relief, as judged by the subject

Exclusion Criteria

• Anatomic obstructions that in the investigator's opinion limit access to the posterior nose
• Altered anatomy of the posterior nose as a result of prior sinus or nasal surgery or injury
• Active nasal or sinus infection
• Moderate to severe ocular allergic symptoms (such as eye tearing [epiphora], itching [pruritus], or redness [erythema])
• History of significant dry eye
• History of any of the following: nose bleeds in the past 3 months, rhinitis medicamentosa, head or neck irradiation
• Known or suspected allergies or contraindications to the anesthetic agents and/or antibiotic medications to be used during the study procedure session
• Known or suspected to be pregnant, or is lactating
• Participating in another clinical research study
• Other medical conditions which in the opinion of the investigator would predispose the subject to poor wound healing, increased surgical risk, or poor compliance with the requirements of the study